DCM Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

DCM Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-672	Closed	-$41K	–	184
2021 Q4	$41K	Sell	672 -1,475	-69%	-$102K	0.01%	208
2021 Q3	$160K	Hold	2,147	–	–	0.06%	233
2021 Q2	$199K	Sell	2,147 -18	-0.8%	-$1.53K	0.11%	187
2021 Q1	$192K	Sell	2,165 -135	-6%	-$13.4K	0.11%	191
2020 Q4	$214K	Buy	+2,300	New	+$183K	0.12%	174

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

DCM Advisors's ARKG Position: Q1 2022 in Review

DCM Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 672 shares — an estimated $41K sold.

DCM Advisors first reported a position in ARKG in Q4 2020 and held it in 5 quarters. The position peaked at $214K in Q4 2020. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

DCM Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
DCM Advisors sold 672 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $41K.
DCM Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 5 quarters.
DCM Advisors's ARK Genomic Revolution ETF position peaked at $214K in Q4 2020.
387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on DCM Advisors's 13F filing for Q1 2022, filed 9 May 2022.